ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

A Pan-Cancer Analysis of CD161, a Potential New Immune Checkpoint

Zhou, Xiaohan; Du, Jun; Liu, Chengdong; Zeng, Hanyi; Chen, Yuting; Liu, Li*; Wu, Dehua*南方医科大学; 中国医学科学院; 中国医学科学院北京协和医院
Frontiers in Immunology2021-7-9DOI: 10.3389/fimmu.2021.688215
34被引3阅读
引用收藏
分享

摘要

Background CD161, encoded by killer cell lectin-like receptor B1 gene, is a newly reported candidate inhibitor of tumour-infiltrating T cells. Antibody-mediated CD161 blockade enhances T cell-mediated killing of cancer cells in vitro and in vivo in several tumour types. We evaluated the role of CD161 using The Cancer Genome Atlas (TCGA) Pan-Cancer Data. Methods CD161 expression was analysed using RNAseq data from TCGA and the Genotype-Tissue Expression (GTEx) database. HPA, GeneCards, and String database were used to explore the protein information of CD161. The prognostic value of CD161 was analysed using clinical survival data from the TCGA. Enrichment analysis of CD161 was conducted using the R package "clusterProfiler". We downloaded the immune cell infiltration score of TCGA samples from published articles and online databases and performed a correlation analysis between immune cell infiltration levels and CD161 expression. We further assessed the association between CD161 and immune checkpoints, immune activating genes, immunosuppressive genes, chemokines, and chemokine receptors. Findings CD161 was differentially expressed and predicted better survival status in most tumour types in TCGA. In addition, CD161 expression was significantly associated with immunoregulatory interactions between lymphoid and non-lymphoid cells. CD161 expression was closely correlated with T cell infiltration, immune checkpoints, immune activating genes, immunosuppressive genes, chemokines, and chemokine receptors. Interpretation Our results suggest that CD161 is a potential cancer biomarker. CD161 might synergize with other immune checkpoints to regulate the immune microenvironment, which could be applied in the development of new-targeted drugs for immunotherapy. Funding This work was supported by the National Nature Science Foundation of China (grant numbers 81773008, 81672756, 81872399, 81972897), the Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2015), the Natural Science Foundation of Guangdong Province (grant number 2017A030311023), the Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program: 2017BT01S131 and the Guangzhou Technology Project (grant number 201804010044), National Key R&D Program of China (Grant Nos. 2020YFC2006400), Key-Area Research and Development Program of Guangdong Province (2019B020227004).

学科与关键词

关键词
TCGAimmune microenvironmentCD161immune checkpointsimmunotherapy
相关
加载中…
  • A pan-cancer and single-cell sequencing analysis of CD161, a promising onco-immunological biomarker in tumor microenvironment and immunotherapy
    Li, He; Zhou, Ke; Wang, Kaiyue; Cao, Hui; Wu, Wantao; Wang, Zeyu; Dai, Ziyu; Chen, Shi; Peng, Yun; Xiao, Gelei; Luo, Peng; Zhang, Jian; Liu, Zaoqu; Cheng, Quan*; Zhang, Hao*Frontiers in Immunology, 2022, 13: 1040289.被引 1
  • Systematic Pan-Cancer Analysis of KLRB1 with Prognostic Value and Immunological Activity across Human Tumors
    Cheng, Xin; Cao, Yucheng; Wang, Xiaowei; Cheng, Lin; Liu, Yaqiong; Lei, Jun; Peng, Weijun*; Shi, Dazun*Journal of Immunology Research, 2022, 2022: 5254911.被引 16
  • Overexpression of TREM1 is Associated with the Immune-Suppressive Microenvironment and Unfavorable Prognosis in Pan-Cancer
    Zhou, Xinwei; Lin, Ke; Fu, Liangmin; Liu, Fei; Lin, Hansen; Chen, Yuhang; Zhuang, Bowen; Liang, Hui; Deng, Qiong; Wang, Zhu; Chen, Wei; Luo, Junhang; Cao, Jiazheng*; Li, Pengju*Journal of Inflammation Research, 2023, 16: 1375-1391.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Immunology
发表日期
2021-07-09
卷期
第 12 卷
页码
688215
DOI
10.3389/fimmu.2021.688215
语言
ENGLISH
期刊收录
NSL
期刊等级
2区
成果收录
SCIE
资助标注
National Nature Science Foundation of China [81773008, 81672756, 81872399, 81972897]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2015); Natural Science Foundation of Guangdong Province [2017A030311023]; Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program [2017BT01S131]; Guangzhou Technology Project [201804010044]; National Key R&D Program of China [2020YFC2006400]; Key-Area Research and Development Program of Guangdong Province [2019B020227004]

作者

  • Z

    Zhou, Xiaohan (第一作者)

    southern med univ

  • D

    Du, Jun

    chinese acad med sci · peking union med coll

查看全部 7 位作者收起作者
  • L

    Liu, Chengdong

    southern med univ

  • Z

    Zeng, Hanyi

    southern med univ

  • C

    Chen, Yuting

    southern med univ

  • L

    Liu, Li (通讯)

    southern med univ

  • W

    Wu, Dehua (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417